Heart Failure Clinical Trials

Find Heart Failure Clinical Trials Near You

Impact of Endovascular Treatment of Aorto-iliac Disease on Systemic Hypertension A Pilot Study Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Hypertension is a major risk factor for a variety of cardiovascular diseases. When hypertension results from increased vascular resistance due to a narrowing of the descending aorta, it can be effectively treated with stenting. More recently, evidence suggest that stenting in more distal parts of the arterial vascular bed is also associated with a reduction in blood pressure. The investigators hypothesize that stenting of occlusions more distal of the descending aorta decreases the central blood pressure and afterload as reflected by NT-proBNP (N-terminal pro-Brain Natriuretic Peptide), a biomarker of intracardiac pressures and predictor of heart failure events. The goal of this pilot study is to prospectively investigate changes in blood pressure after stent placement in the aorto-iliac region.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years

• Singed informed consent

• Chronic occlusion in the infrarenal aorta and/or one or both common iliac arteries

• Total lesion length of ≥30mm

• Clinical indication for treatment of the pathology (Chronic limb threatening ischemia or disabling intermittent claudication not responding to supervised exercise training)

Locations
Other Locations
Netherlands
Rijnstate
RECRUITING
Arnhem
Contact Information
Primary
Michel Reijnen, prof.dr.
vascularsurgery@rijnstate.nl
0031 88 005 7282
Time Frame
Start Date: 2026-03-30
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 20
Treatments
Other: Stent placement
Patients with an aorto-iliac occlusion will receive a stent, according to standard care
Related Therapeutic Areas
Sponsors
Leads: Rijnstate Hospital

This content was sourced from clinicaltrials.gov